Dawn of a new era: the completely interventionally treated patient
- PMID: 26994050
- PMCID: PMC4800197
- DOI: 10.1136/bcr-2015-214268
Dawn of a new era: the completely interventionally treated patient
Abstract
A frail 75-year-old woman with permanent atrial fibrillation and angina pectoris was admitted to our department for further evaluation. Echocardiography revealed concurrent severe aortic valve stenosis. Furthermore, significant coronary artery stenoses were identified on the coronary angiogram. We chose the following treatment strategy: first, two drug eluting stents were implanted successfully in the left anterior descending and circumflex artery, respectively. Second, a 23 mm Core Valve bioprosthesis (Medtronic Inc, Minneapolis, Minnesota, USA) was implanted without complications within the same session. Two weeks after hospital discharge, the patient showed up at our outpatient department, with a symptomatic complete atrioventricular-block with an escape rhythm of 35 bpm. Thus, finally, a leadless pacemaker Micra (Medtronic Inc) was implanted via a transvenous transfemoral access without any complications.
2016 BMJ Publishing Group Ltd.
Figures
References
-
- von Birgelen C, Sen H, Lam MK et al. . Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. Lancet 2014;383:413–23. 10.1016/S0140-6736(13)62037-1 - DOI - PubMed
-
- Arnold SV, Reynolds MR, Wang K et al. . Health status after Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: result from the CoreValve US pivotal trial. JACC Cardiovasc Interv 2015;8:1207–17. 10.1016/j.jcin.2015.04.018 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical